Global Conjugate Vaccines Market Research Report 2023(Status and Outlook)

Global Conjugate Vaccines Market Research Report 2023(Status and Outlook)



Report Overview

Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.

This protein has a key role in enhancing the immunogenic property of the polysaccharide. These vaccines are mainly used to immunize infants and children against invasive disease caused by Hib bacteria, H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis.

The Global Conjugate Vaccines Market Size was estimated at USD 11550.00 million in 2022 and is projected to reach USD 16690.38 million by 2029, exhibiting a CAGR of 5.40% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Conjugate Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Conjugate Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Conjugate Vaccines market in any manner.

Global Conjugate Vaccines Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

Neuron Biotech

Serum Institute of India

Pfizer

Sanofi Pasteur

Bharat Biotech

Biological

GlaxoSmithKline

Merck

CSL

Market Segmentation (by Type)

Monovalent Conjugate Vaccines

Multivalent Conjugate Vaccines

Market Segmentation (by Application)

Automotive

Electronics

Biomedical

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Conjugate Vaccines Market

Overview of the regional outlook of the Conjugate Vaccines Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Conjugate Vaccines
1.2 Key Market Segments
1.2.1 Conjugate Vaccines Segment by Type
1.2.2 Conjugate Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Conjugate Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Conjugate Vaccines Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Conjugate Vaccines Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Conjugate Vaccines Market Competitive Landscape
3.1 Global Conjugate Vaccines Sales by Manufacturers (2018-2023)
3.2 Global Conjugate Vaccines Revenue Market Share by Manufacturers (2018-2023)
3.3 Conjugate Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Conjugate Vaccines Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Conjugate Vaccines Sales Sites, Area Served, Product Type
3.6 Conjugate Vaccines Market Competitive Situation and Trends
3.6.1 Conjugate Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Conjugate Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Conjugate Vaccines Industry Chain Analysis
4.1 Conjugate Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Conjugate Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Conjugate Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Conjugate Vaccines Sales Market Share by Type (2018-2023)
6.3 Global Conjugate Vaccines Market Size Market Share by Type (2018-2023)
6.4 Global Conjugate Vaccines Price by Type (2018-2023)
7 Conjugate Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Conjugate Vaccines Market Sales by Application (2018-2023)
7.3 Global Conjugate Vaccines Market Size (M USD) by Application (2018-2023)
7.4 Global Conjugate Vaccines Sales Growth Rate by Application (2018-2023)
8 Conjugate Vaccines Market Segmentation by Region
8.1 Global Conjugate Vaccines Sales by Region
8.1.1 Global Conjugate Vaccines Sales by Region
8.1.2 Global Conjugate Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Conjugate Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Conjugate Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Conjugate Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Conjugate Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Conjugate Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis
9.1.1 Novartis Conjugate Vaccines Basic Information
9.1.2 Novartis Conjugate Vaccines Product Overview
9.1.3 Novartis Conjugate Vaccines Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Conjugate Vaccines SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Neuron Biotech
9.2.1 Neuron Biotech Conjugate Vaccines Basic Information
9.2.2 Neuron Biotech Conjugate Vaccines Product Overview
9.2.3 Neuron Biotech Conjugate Vaccines Product Market Performance
9.2.4 Neuron Biotech Business Overview
9.2.5 Neuron Biotech Conjugate Vaccines SWOT Analysis
9.2.6 Neuron Biotech Recent Developments
9.3 Serum Institute of India
9.3.1 Serum Institute of India Conjugate Vaccines Basic Information
9.3.2 Serum Institute of India Conjugate Vaccines Product Overview
9.3.3 Serum Institute of India Conjugate Vaccines Product Market Performance
9.3.4 Serum Institute of India Business Overview
9.3.5 Serum Institute of India Conjugate Vaccines SWOT Analysis
9.3.6 Serum Institute of India Recent Developments
9.4 Pfizer
9.4.1 Pfizer Conjugate Vaccines Basic Information
9.4.2 Pfizer Conjugate Vaccines Product Overview
9.4.3 Pfizer Conjugate Vaccines Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Conjugate Vaccines SWOT Analysis
9.4.6 Pfizer Recent Developments
9.5 Sanofi Pasteur
9.5.1 Sanofi Pasteur Conjugate Vaccines Basic Information
9.5.2 Sanofi Pasteur Conjugate Vaccines Product Overview
9.5.3 Sanofi Pasteur Conjugate Vaccines Product Market Performance
9.5.4 Sanofi Pasteur Business Overview
9.5.5 Sanofi Pasteur Conjugate Vaccines SWOT Analysis
9.5.6 Sanofi Pasteur Recent Developments
9.6 Bharat Biotech
9.6.1 Bharat Biotech Conjugate Vaccines Basic Information
9.6.2 Bharat Biotech Conjugate Vaccines Product Overview
9.6.3 Bharat Biotech Conjugate Vaccines Product Market Performance
9.6.4 Bharat Biotech Business Overview
9.6.5 Bharat Biotech Recent Developments
9.7 Biological
9.7.1 Biological Conjugate Vaccines Basic Information
9.7.2 Biological Conjugate Vaccines Product Overview
9.7.3 Biological Conjugate Vaccines Product Market Performance
9.7.4 Biological Business Overview
9.7.5 Biological Recent Developments
9.8 GlaxoSmithKline
9.8.1 GlaxoSmithKline Conjugate Vaccines Basic Information
9.8.2 GlaxoSmithKline Conjugate Vaccines Product Overview
9.8.3 GlaxoSmithKline Conjugate Vaccines Product Market Performance
9.8.4 GlaxoSmithKline Business Overview
9.8.5 GlaxoSmithKline Recent Developments
9.9 Merck
9.9.1 Merck Conjugate Vaccines Basic Information
9.9.2 Merck Conjugate Vaccines Product Overview
9.9.3 Merck Conjugate Vaccines Product Market Performance
9.9.4 Merck Business Overview
9.9.5 Merck Recent Developments
9.10 CSL
9.10.1 CSL Conjugate Vaccines Basic Information
9.10.2 CSL Conjugate Vaccines Product Overview
9.10.3 CSL Conjugate Vaccines Product Market Performance
9.10.4 CSL Business Overview
9.10.5 CSL Recent Developments
10 Conjugate Vaccines Market Forecast by Region
10.1 Global Conjugate Vaccines Market Size Forecast
10.2 Global Conjugate Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Conjugate Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Conjugate Vaccines Market Size Forecast by Region
10.2.4 South America Conjugate Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Conjugate Vaccines by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Conjugate Vaccines Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Conjugate Vaccines by Type (2024-2029)
11.1.2 Global Conjugate Vaccines Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Conjugate Vaccines by Type (2024-2029)
11.2 Global Conjugate Vaccines Market Forecast by Application (2024-2029)
11.2.1 Global Conjugate Vaccines Sales (K Units) Forecast by Application
11.2.2 Global Conjugate Vaccines Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings